NGVT — Ingevity Income Statement
0.000.00%
Last trade - 00:00
- $1.76bn
- $3.13bn
- $1.69bn
- 78
- 58
- 91
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,293 | 1,216 | 1,392 | 1,668 | 1,692 |
Cost of Revenue | |||||
Gross Profit | 482 | 466 | 513 | 570 | 472 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,065 | 981 | 1,229 | 1,399 | 1,702 |
Operating Profit | 228 | 235 | 163 | 270 | -10.1 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 228 | 235 | 163 | 270 | -10.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 184 | 181 | 118 | 212 | -5.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 184 | 181 | 118 | 212 | -5.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 184 | 181 | 118 | 212 | -5.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.9 | 4.77 | 4.79 | 5.89 | 3.39 |